Pharmacokinetic evaluation of paclitaxel in South Indian cancer patients: A prospective study

Journal of Young Pharmacists

Volumn 3, Issue 4, 2011, Pages 322-328

  Vasantha, J ^a   Kannan, G ^a   Goud, T ^a   Palani, T ^a   Vanitha, R ^a   Anitha, R ^a   Priya, J M M ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Non linear; optimization; pharmacokinetics; plasma concentrations; taxane

Indexed keywords

AMTAX; CYTAX; PACLIRON; PACLITAXEL; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIAN; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NEOPLASM; PRIORITY JOURNAL; REVIEW;

EID: 82955225399     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.90245     Document Type: Review

References (18)

1. Huizing MT, Sewberath Misser VH, Pieters RC, Bokkel Huinink WW, Veenhof CH, Vermorken JB, et al. Taxanes: A new class of antitumor agents. Cancer Invest 1995;13:381-404.
2. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995;332:1004-14.
3. Huizing MT, Keung AC, Rosing H, Van der Kuij V, Bokkel Huinink WW, Mandjes IM, et al. Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum pretreated ovarian cancer patients. J Clin Oncol 1993;11:2127-35. (Pubitemid 23332248)
4. Sonnichsen DS, Hurwitz CA, Pratt CB, Shuster JJ, Relling MV. Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. J Clin Oncol 1994;12:532-8. (Pubitemid 24079895)
5. Gianni L, Kearns CM, Giani A, Capri G, Vigano L, Lacatelli A, et al. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol 1995;13:180-90.
6. Kearns CM, Gianni L, Egorin MJ. Paclitaxel pharmacokinetics and pharmacodynamics. Semin Oncol 1995;22:16-23.
7. Huizing MT, Giaccone G, Van Warmerdam LJ, Rosing H, Bakker PJ, Vermorken JB, et al. Pharmacokinetics of paclitaxel and carboplatin in a dose escalating and dose-sequencing study in patients with non-small-cell lung cancer. J Clin Oncol 1997;15:317-29. (Pubitemid 27020590)
8. Mross K. The pharmacokinetics of a 1-h paclitaxel infusion. Cancer Chemother Pharmacol 2000;45:463-70. (Pubitemid 30316906)
9. Rowland M. Clinical Pharmacokinetics concepts and applications. 3 rd ed. London: Lippincott Williams and Wilkins; 2000. p. 11-83.
10. Lorigan PC, Crosby T, Coleman RE. Current drug treatment guideline for epithelial ovarian cancer. Drugs 1996;51:571-84. (Pubitemid 26108469)
11. Mielke S, Sparreboom A, Behringer D, Mross K. Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimen. Anticancer Res 2005;25:4423-8.
12. Shah VP, Midha KK, Dighe S, McGilveray IJ, Byrnes JP, Skelly JB, et al. Analytical methods validation: Bioavailability, bio equivalence and pharmacokinetic studies. J Pharm Sci 1992;81:309-12.
13. Sparreboom A. Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid Chromatography with ultraviolet detection. J Chromatogr B 1998;705:159-64. (Pubitemid 28045670)
14. Hurwitz CA, Relling MV, Weitman SD, Ravindranath Y, Vieni TJ, Strother DR, et al. Phase I trial of paclitaxel in children with refractory solid tumors: A Pediatric Oncology Group study. J Clin Oncol 1994;2:2324-9.
15. Schiller JH, Tutsch K, Arzoomanian R, Alberti FC, Spriggs D. Phase I trial of a 3 hour taxol infusion plus or minus granulocyte colony stimulating factor (G-CSF). Proc Am Soc Clin Oncol 1993;12:166.
16. Vinoth R. Phramacokinetics of paclitaxel administered as a 3-hour or 96-hour infusion, Pharmacol Res 1999;40:67-74.
17. Ohtsu T, Sasaki Y. Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion. Clin Cancer Res 1995; 1:599-606.
18. Catalin J. Assay of paclitaxel in plasma and urine by high performance liquid chromatography. J Chromatogr B 1998;709:281-8. (Pubitemid 28255361)